News
AstraZeneca PLC ADR closed 14.46% short of its 52-week high of $87.68, which the company reached on August 30th.
As new priorities demand greater resources, the health sector risks significant cuts in the upcoming long-term EU budget.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback